ETON PHARMACEUTICALS INC (ETON) — institutional ownership
179 funds reported holding ETON PHARMACEUTICALS INC in their latest 13F filings, worth $761M in total (CUSIP 29772L108).
Largest holders
- Opaleye Management Inc. — $104M
- EcoR1 Capital, LLC — $78.6M
- BlackRock, Inc. (BLK) — $68.6M
- Nantahala Capital Management, LLC — $42.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $35.4M
- MORGAN STANLEY (MS, MS-PA, MS-PE, MS-PF, MS-PI, MS-PK, MS-PL, MS-PO, MS-PP, MS-PQ) — $27.8M
- STATE STREET CORP (STT, STT-PG) — $25.4M
- GEODE CAPITAL MANAGEMENT, LLC — $23.6M
- VANGUARD GROUP INC — $22.8M
- OBERWEIS ASSET MANAGEMENT INC/ — $18.2M
Famous investors holding it
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
Insider buying and selling at ETON PHARMACEUTICALS INC
Who owns the most ETON stock?
The largest institutional holders in the latest 13F filings are Opaleye Management Inc. ($104M), EcoR1 Capital, LLC ($78.6M), BlackRock, Inc. (BLK) ($68.6M).
How many funds own ETON?
179 funds reported holding it, worth $761M in total.